SCHEMBL30664591

SCHEMBL30664591

COC(=O)Cc1cc(N)ccc1N1CCN(C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
MAPT P10636 4/20 0.50
RAD52 P43351 1/20 0.50
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
WDR5 P61964 1/20 0.40
ADRA2C P18825 2/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GFER P55789 2/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
YWHAG P61981 1/20 0.40
GAA P10253 2/20 0.40
PTK2B Q14289 1/20 0.40
ESR2 Q92731 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664596 1.00 KDM4E (0.50) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL26655902 1.00 KDM4E (0.50) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL26655888 0.85 KDM4E (0.54) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL6663891 0.81 NCF1 (0.51) SMN1; SMN2POLBL3MBTL1ADRA2CKMT2A
SCHEMBL26655887 0.80 ALDH1A1 (0.55) KDM4EALDH1A1POLBWDR5KMT2A
SCHEMBL30879098 0.80 MAPT (0.61) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL12006141 0.80 MAPT (0.61) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL13215402 0.80 KDM4E (0.48) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL22450644 0.79 MAPT (0.56) KDM4EMAPTRAD52ALDH1A1HSD17B10
SCHEMBL189132 0.79 MAPT (0.59) KDM4EMAPTRAD52ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526307-A1 PYRIMIDOPYRIMIDONE COMPOUNDS AND METHODS OF USE THEREOF Soltego, Inc. (US) 2025-03-26 EP disclosed
WO-2023225097-A1 PYRIMIDOPYRIMIDONE COMPOUNDS AND METHODS OF USE THEREOF SOLTEGO, INC. (US) 2023-11-23 WO disclosed